Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

112 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind41
Udgave nummer9
Sider (fra-til)e133-e135
ISSN1733-5671
DOI
StatusUdgivet - 1. sep. 2018

Citationsformater